Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
P1.01 - Early Detection and Screening - Biomarkers
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Early Detection and Screening - Biomarkers
-
+
P1.01-01 - Comparison between Protein and Autoantibody Biomarkers for the Early Detection of Lung Cancer
Presenter: Xiaoshuang Feng- Abstract
Loading...
-
+
P1.02 - Early Detection and Screening - Implementation
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Early Detection and Screening - Implementation
-
+
P1.02-02 - Current Status, Challenges and Perspectives of Lung Cancer Screening in Low- and Middle-Income Countries
Presenter: Milena Cavic- Abstract
Loading... -
+
P1.02-03 - Budget Impact Analysis of Volume CT Lung Cancer Screening Based on NELSON Study Outcomes in Europe
Presenter: Xuanqi Pan- Abstract
Loading... -
+
P1.02-04 - Spatial Access to Lung Screening in British Columbia, Canada
Presenter: Stephen Lam- Abstract
Loading...
-
+
P1.03 - Early Detection and Screening - Pulmonary Nodule
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Early Detection and Screening - Pulmonary Nodule
-
+
P1.03-01 - Do We Follow Incidental Lung Nodules Appropriately? A Retrospective Study
Presenter: Jasleen Kaur Pannu- Abstract
Loading...
-
+
P1.04 - Early Detection and Screening - Risk Stratification
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Early Detection and Screening - Risk Stratification
-
+
P1.04-01 - Risk Stratification for Personalised Screening Intervals: Performance of PLCOm2012NoRace at Second Round of Manchester LHC
Presenter: Patrick Bradley- Abstract
Loading... -
+
P1.04-02 - Optimizing Screening Frequency and Interval Using a Deep Learning Algorithm
Presenter: Stephen Lam- Abstract
Loading... -
+
P1.04-03 - Independent Validation of the Maisonneuve Lung Cancer Risk Model to Optimize Screening Interval in High-risk Individuals
Presenter: Giulia Veronesi- Abstract
Loading...
-
+
P1.05 - Early Stage Non-small Cell - Biomarkers
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Early Stage Non-small Cell - Biomarkers
-
+
P1.05-01 - Phase II Study of ctDNA Directed Consolidation Durvalumab After Induction and Concurrent Durvalumab with SABR for Stage I NSCLC
Presenter: Islam Mohamed- Abstract
Loading... -
+
P1.05-02 - Mutations in CREBBP are Associated with Local Failure after Lung Stereotactic Body Radiation Therapy
Presenter: Victor Chan Ng- Abstract
Loading...
-
+
P1.06 - Early Stage Non-small Cell - Systemic Therapy
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Early Stage Non-small Cell - Systemic Therapy
-
+
P1.06-01 - Adjuvant Osimertinib vs Placebo in Completely Resected Stage IA2-IA3 EGFR-mutated NSCLC: The ADAURA2 Phase III Study
Presenter: Toon Van der Gronde- Abstract
Loading...
-
+
P1.07 - Epidemiology
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Epidemiology
-
+
P1.07-01 - Early Detection Plus Timely Surgery Remains the Standard despite Advances in Immunotherapy
Presenter: Emanuela Taioli- Abstract
Loading... -
+
P1.07-02 - Personal and Family HiStory of CANcer in Patients with Non-small Cell Lung Cancer: Preliminary Data of the SCAN Study
Presenter: Juan Carlos Laguna- Abstract
Loading...
-
+
P1.08 - Global Health, Health Services Research, and Health Economics - Cost issues
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Global Health, Health Services Research, and Health Economics - Cost issues
-
+
P1.08-01 - Updated Costs and Survival Expectations for Stage IV Lung Cancer in Australia
Presenter: Preston Ngo- Abstract
Loading...
-
+
P1.09 - Global Health, Health Services Research, and Health Economics - Support to Patients and Staff
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Global Health, Health Services Research, and Health Economics - Support to Patients and Staff
-
+
P1.09-01 - The Lung Cancer Patient Experience and Care Pathway: A Multi-Country Survey
Presenter: Pauline Frank- Abstract
Loading... -
+
P1.09-02 - Real-world Clinical Characteristics and Treatment Patterns of METExon 14 Skipping Mutation in Advanced/Metastatic NSCLC
Presenter: Xiuning Le- Abstract
Loading... -
+
P1.09-03 - Multidisciplinary Thoracic Tumors Board Survey in Spain
Presenter: Bartomeu Massutí- Abstract
Loading...
-
+
P1.10 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
-
+
P1.10-01 - Phase 3 Study of Durvalumab Combined with Oleclumab or Monalizumab in Patients with Unresectable Stage III NSCLC (PACIFIC-9)
Presenter: Aarthi Gopinathan- Abstract
Loading... -
+
P1.10-02 - ImmunoPET: A Phase 0/1 Study Characterising PD-L1 with 89Zr-Durvalumab (MEDI4736) PET/CT in Stage III NSCLC Patients Receiving Chemoradiation
Presenter: Fiona Hegi-Johnson- Abstract
Loading... -
+
P1.10-03 - A Deep Learning Auto-Segmentation Tool for Cardiac Substructures in 4D Radiotherapy Planning for Locally Advanced Lung Cancer
Presenter: Gerard M Walls- Abstract
Loading... -
+
P1.10-04 - Impact of Radiation Dose to the Immune Cells in Unresectable or Stage III Non-Small Cell Lung Cancer in the Durvalumab Era
Presenter: Neal Sean Mccall- Abstract
Loading...